Evidence map›Paper›PMID 40747837›Full record

ArticleThe Laryngoscope2026

Development of the Chronic Sialadenitis Outcome Test-14 for Chronic Sialadenitis.

Juha Vartiainen, Riitta Saarinen, Juha Laakso, Johanna Jokela, Anu Haaramo, Aaro Haapaniemi, Aarno Dietz, Saku T Sinkkonen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Juha VartiainenDepartment of Otorhinolaryngology, Päijät-Häme Central Hospital, Lahti, Finland.ORCID 0009-0008-0649-057X
Riitta SaarinenDepartment of Otorhinolaryngology-Head and Neck Surgery, Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Juha LaaksoDepartment of Otorhinolaryngology-Head and Neck Surgery, Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Johanna JokelaDepartment of Otorhinolaryngology, Hospital Nova of Central Finland, Jyväskylä, Finland.
Anu HaaramoDepartment of Otorhinolaryngology-Head and Neck Surgery, Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Aaro HaapaniemiDepartment of Otorhinolaryngology-Head and Neck Surgery, Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0003-3097-1118
Aarno DietzDepartment of Otorhinolaryngology-Head and Neck Surgery, Kuopio University Hospital and University of Kuopio, Kuopio, Finland.
Saku T SinkkonenDepartment of Otorhinolaryngology-Head and Neck Surgery, Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Funding

Helsingin ja Uudenmaan SairaanhoitopiiriThe State Research Funding
6 · The paper itself

Abstract

objectivePatient perspectives have become an important aspect of healthcare evaluation. To measure health related quality of life (HRQoL), it is essential to apply well-researched HRQoL instruments. Current instruments for chronic sialadenitis have limitations and, thus, we created a new disease-specific HRQoL tailored for chronic sialadenitis.

methodsCOSMIN guidelines were followed. Initially, a preliminary 24-item questionnaire was created. Untreated patients (n = 126) were recruited to complete the preliminary questionnaire alongside the generic HRQoL instrument, 15D. ENT specialists evaluated the severity of the disease and the disability caused by the disease. Additionally, a control group of healthy adults was recruited for comparison. Based on patients' responses, items were reduced using predefined criteria, and the final instrument was validated with statistical analyses. Cronbach's α was used to measure internal consistency, and the intraclass correlation coefficient (ICC) was used to measure test-retest reliability.

resultsThe most suitable recall period was 3 months. With statistical analyses, the number of items was reduced to 14, leading to the creation of the final instrument, the Chronic Sialadenitis Outcome Test 14, CSOT-14. CSOT-14 had good internal consistency (Cronbach's α = 0.871) and test-retest reliability (ICC = 0.911), and it differentiated patients from healthy controls.

conclusionsA novel instrument for chronic sialadenitis, CSOT-14, that clearly differentiated patients from healthy controls was created and validated. The instrument can be used in daily clinical practice for patients with chronic sialadenitis. LEVEL OF EVIDENCE: 2:

Indexed as

Quality of LifeSialadenitisAdultAgedCase-Control StudiesChronic DiseaseFemaleHumansMaleMiddle AgedReproducibility of ResultsSeverity of Illness IndexSurveys and Questionnairesquality of lifesialadenitissialendoscopy

Identifiers

PMID40747837
PMCPMC12770803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.